[HTML][HTML] Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

J Duraiswamy, R Turrini, A Minasyan, D Barras… - Cancer cell, 2021 - cell.com
The mechanisms regulating exhaustion of tumor-infiltrating lymphocytes (TIL) and
responsiveness to PD-1 blockade remain partly unknown. In human ovarian cancer, we …

Genetic and molecular changes in ovarian cancer

RL Hollis, C Gourley - Cancer biology & medicine, 2016 - cancerbiomed.org
Epithelial ovarian cancer represents the most lethal gynecological malignancy in the
developed world, and can be divided into five main histological subtypes: high grade …

BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression

H Zhu, F Bengsch, N Svoronos, MR Rutkowski… - Cell reports, 2016 - cell.com
Restoration of anti-tumor immunity by blocking PD-L1 signaling through the use of
antibodies has proven to be beneficial in cancer therapy. Here, we show that BET …

[PDF][PDF] Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

B Gyorffy, A Lánczky, Z Szállási - Endocrine Related Cancer, 2012 - core.ac.uk
The validation of prognostic biomarkers in large independent patient cohorts is a major
bottleneck in ovarian cancer research. We implemented an online tool to assess the …

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

S Shen, G Wang, R Zhang, Y Zhao, H Yu, Y Wei… - …, 2019 - thelancet.com
Background Ovarian cancer (OV) is the most lethal gynecological cancer in women. We aim
to develop a generalized, individualized immune prognostic signature that can stratify and …

Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer

AE Teschendorff, U Menon, A Gentry-Maharaj… - Genome …, 2010 - genome.cshlp.org
Polycomb group proteins (PCGs) are involved in repression of genes that are required for
stem cell differentiation. Recently, it was shown that promoters of PCG target genes (PCGTs) …

[HTML][HTML] Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis

L Li, Q Lei, S Zhang, L Kong, B Qin - Oncology reports, 2017 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Intense
efforts have been made to elucidate the pathogeny, but the molecular mechanisms of HCC …

Semi-supervised learning improves gene expression-based prediction of cancer recurrence

M Shi, B Zhang - Bioinformatics, 2011 - academic.oup.com
Motivation: Gene expression profiling has shown great potential in outcome prediction for
different types of cancers. Nevertheless, small sample size remains a bottleneck in obtaining …

[PDF][PDF] YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors

P Marti, C Stein, T Blumer, Y Abraham, MT Dill… - …, 2015 - Wiley Online Library
The Yes‐associated protein (YAP)/Hippo pathway has been implicated in tissue
development, regeneration, and tumorigenesis. However, its role in cholangiocarcinoma …